Abstract
Abstract
Traumatic brain injury (TBI) triggers a severe cerebral energy crisis causing irreversible neurodegeneration, with no effective targeted therapies available. Traditional TBI research neglects the secretory function of cerebral endothelial cells (CECs), and this study explored whether CEC-derived exosomes (CEC-Exos) exert SDF-1α/CXCR4-mediated lesion homing and rescue TBI-induced energy dysfunction, as well as the underlying mechanism. CECs endogenously express CXCR4, and TBI upregulates SDF-1α in the injured microenvironment; CEC-Exos inherit this SDF-1α/CXCR4-mediated homing property, which is attenuated by siCXCR4 knockdown. Multi-omics identified miR-16-5p as the key exosomal effector that orchestrates cerebral metabolic rewiring, redirecting glucose metabolism from glycolysis to mitochondrial oxidative phosphorylation, reversing the TBI-induced energy crisis and restoring ATP production. In murine TBI models, CEC-Exos alleviated cerebral glucose hypometabolism, reduced lesion volume and neuronal apoptosis, and improved neurological recovery with these effects abolished by miR-16-5p depletion. Collectively, CEC-Exos serve as endogenous targeted therapeutic agents for TBI via SDF-1α/CXCR4-mediated homing and miR-16-5p-dependent metabolic regulation. We also propose a novel neurovascular coupling mechanism where CEC-Exos act as “endogenous neuro-metabolic couplers” to improve neuronal energy metabolism, offering a new TBI treatment strategy.